Rev-erb α agonist SR9009 protects against cerebral ischemic injury through mechanisms involving Nrf2 pathway

Conclusion: Taken together, Rev-erbα activation by SR9009 protects against ischemic stroke damage, at least, partly through Nrf2 pathway.PMID:37063298 | PMC:PMC10102520 | DOI:10.3389/fphar.2023.1102567

Source: Pharmacological Reviews - April 17, 2023 Category: Drugs & Pharmacology Authors: Mingyue Sheng Xun Chen Yan Yu Qi Wu Junping Kou Gangling Chen Source Type: research